Foetal malformations and seizure control: 52 Months data of the Australian Pregnancy Registry

European Journal of Neurology

Volumn 13, Issue 6, 2006, Pages 645-654

  Vajda, F J E ^a,b   Hitchcock, A ^b   Graham, J ^b   Solinas, C ^b   O'Brien, T J ^c   Lander, C M ^d   Eadie, M J ^d  

^a MONASH UNIVERSITY   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Antiepileptic drugs; Categories of malformations; Epilepsy; Malformations; Pregnancy; Seizure control; Valproate dose related malformations

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; DIAZEPAM; LAMOTRIGINE; PHENYTOIN; TOPIRAMATE; VALPROIC ACID;

ADULT; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE REGISTRY; EPILEPTIC STATE; FEMALE; FETUS MALFORMATION; FETUS WASTAGE; GENERALIZED EPILEPSY; HUMAN; INCIDENCE; INTERVIEW; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SEIZURE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TERATOGENICITY;

ABNORMALITIES, DRUG-INDUCED; ADULT; ANTICONVULSANTS; AUSTRALIA; FEMALE; FETAL DEVELOPMENT; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PROSPECTIVE STUDIES; REGISTRIES; RETROSPECTIVE STUDIES; SEIZURES;

EID: 33745033039     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2006.01359.x     Document Type: Article

References (37)

1. Morrow JI Craig J. Antiepileptic drugs in pregnancy: current safety and other issues. Expert Opinion in Pharmacotherapy 2003 4 : 445 456.
2. Teramo K Hilesmaa V Bardy A Saarikoski S. Fetal heart rate during a maternal grand mal epileptic seizure. Journal of Perinatal Medicine 1979 7 : 3 6.
3. Tomson T Perucca E Battino D. Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy. Epilepsia 2004 45 : 1171 1175.
4. Kaaja E Kaaja R Hiilesmaa V. Major malformations in offspring of women with epilepsy. Neurology 2003 60 : 575 579.
5. Vajda FJ O'Brien TJ Hitchcock A, et al. Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy. Journal of Clinical Neuroscience 2004 11 : 854 858.
6. Perinatal Data Collection Unit. Birth Defects in Victoria 1983-1988. Melbourne : Public Health Division, Department of Human Services, 1988.
7. Vajda FJE Eadie MJ. Maternal valproate dosage and foetal malformations. Acta Neurologica Scandinavica 2005 112 : 137 143.
8. Tennis P Eldridge RR. Preliminary results on pregnancy outcomes in women using lamotrigine. Epilepsia 2002 43 : 1161 1167.
9. Sabers A Dam M A-Rogvi-Hansen B, et al. Epilepsy and pregnancy: lamotrigine as main drug used. Acta Neurologica Scandinavia 2004 109 : 9 13.
10. Patsalos PN. Anticonvulsants combination and interactions. In : Eadie MJ Vajda FE, eds. Handbook of Experimental Pharmacology Antiepileptic Drugs. Springer : Heidelberg, 1999 : 101 138.
11. Patsalos PN Perucca E. Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. Lancet Neurology 2003 2 : 347 356.
12. Omtzigt JG Los FJ Grobbee DE, et al. The risk of spina bifida aperta after the first trimester exposure to valproate in a prenatal cohort. Neurology 1992 42 Suppl. 5 S119 S125.
13. Holmes LB Wyszynski DF Liberman E. The AED (Antiepileptic Drug) Pregnancy Registry. Archives of Neurology 2004 61 : 673 678.
14. Lindhout D Omtzigt JG Cornel MC. Spectrum of neural tube defect in 34 infants prenatally exposed to antiepileptic drugs. Neurology 1992 42 Suppl. 5 S111 S118.
15. Leppik IE Rask CA. Pharmacokinetics of antiepileptic drugs during pregnancy. Seminars in Neurology 1988 8 : 240 246.
16. Vajda FJE Angelis-Stoforidis P Eadie MJ. Utility of Plasma Lamotrigine Concentrations. Concept of the Plasma Therapeutic Range for Individual Patients. Milan : Annual Scientific Meeting of European Neurological Society, 1999. June 5-10 1999. J Neurol 1999; 246 (Suppl. 1): 1/1-1/196 Springer-Verlag 1999.
17. Sabers A Gram L. Newer anticonvulsants: comparative review of drug interactions and adverse effects. Drugs 2000 60 : 23 33.
18. Sabers A Buchholt JM Uldall P Hansen EL. (a) Lamotrigine plasma levels reduced by oral contraceptives. Epilepsy Research 2001 47 : 151 154.
19. Yerby MS. Clinical Care of pregnant women with epilepsy: neural tube defects and folic acid supplementation. Epilepsia 2003a 44 Suppl. 3 33 40.
20. Yerby MS. Management issues for women with epilepsy. Neural tube defects and folic acid supplementation. Neurology 2003b 61 Suppl. 2 S23 S26.
21. MRC Vitamin study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991 338 : 131 137.
22. Czeizel AE Dudas I. Prevention of the first occurrence of neural tube defects by periconceptual vitamin supplementation. New England Journal of Medicine 1992 327 : 1832 1835.
23. Rosenberg IH. Folic acid and neural-tube defects-time for action New England Journal of Medicine 1992 327 : 1875 1877.
24. Dansky LV Rosenblatt DS Andermann E. Mechanisms of teratogenesis: folic acid and antiepileptic therapy. Neurology 1992 42 Suppl. 17 24.
25. Craig J Morrison P Morrow J et al. Failure of periconceptual folic acid to prevent a neural tube defect in the offspring of a mother taking sodium valproate. Seizure 1999 8 : 253 254.
26. Duncan S Mercho S Lopes-Cendes I, et al. Repeated neural tube defects and valproate monotherapy suggest a pharmacogenetic abnormality. Epilepsia 2001 42 : 750 753.
27. Canger R Battino D Canevini MP et al. Malformations in offspring of women with epilepsy: a prospective study. Epilepsia 1999 40 : 1231 1236.
28. Malm H Kajantie E Kivirikko S Kaariainen H Peippo M Somer M. Valproate embryopathy in three sets of siblings: further proof of hereditary susceptibility. Neurology 2002 59 : 630 633.
29. Gaily E Granstrom Ml Hilesmaa V Bardy A. Minor abnormalities in children of mothers with epilepsy. Journal of Paediatrics 1988 112 : 520 529.
30. Steegers-Theunissen RP Renier W Borm GF et al. Factors influencing the risk of abnormal pregnancy outcome in epileptic women: a multi centre prospective study. Epilepsy Research 1994 18 : 479 495.
31. Teramo K Hilesmaa V. Pregnancy and fetal complications in epileptic pregnancies. In : Janz D Dam M Richens A Bossi L Helge H Schmidt D, eds. Epilepsy, Pregnancy and the Child. NY, USA : Raven Press, 1982.
32. Nakane Y Okuma T Takahashi R, et al. Multiinstitutional study on teratogenicity and fetal toxicity of antiepileptic drugs: a report of a collaborative study group in Japan. Epilepsia 1980 21 : 663 680.
33. Kaneko S Otani K Fukushima Y, et al. Teratogenicity of antiepileptic drugs: analysis of possible risk factors. Epilepsia 1988 29 : 459 467.
34. Nicolson A Appleton RE Chadwick DW Smith DF. The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies. Journal of Neurology Neurosurgery and Psychiatry 2004 75 : 75 79.
35. Ohman I Vitols S Tomson T. Lamotrigine in Pregnancy: pharmacokinetics during delivery, in the neonate and during lactation. Epilepsia 2000 41 : 709 713.
36. Tran TA Leppik IE Blesi K Sathananandan ST Remmel R. Lamotrigine clearance during pregnancy. Neurology 2002 59 : 251 255.
37. Pennel PB Newport DJ Stowe MD Helmers SL Montgomery JQ Henry TR. The impact of pregnancy and childbirth on the metabolism of lamotrigine. Neurology 2004 62 : 292 295.